Nov 06, 2018 — Revenue Placements up 40 Percent in U.S., Total Revenue up 64 Percent TUCSON, Ariz., Nov. 6, 2018 /PRNewswire/ — Accelerate Diagnostics, Inc. today announced financial results for the quarter ending September 30, 2018. The company reported a 40% increase in U.S. instruments placed under commercial contract, and revenue for the quarter of $1.3 million, an […]
Aug 07, 2018 — TUCSON, Ariz., Aug. 7, 2018 /PRNewswire/ — Accelerate Diagnostics, Inc. announced today that it received an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the United States. The contract was based on a recommendation of the Accelerate Pheno™ system by hospital experts in this category who serve on […]
Aug 06, 2018 — Revenue up 142 Percent, Global install base up 25 Percent TUCSON, Ariz., Aug. 6, 2018 /PRNewswire/ — Accelerate Diagnostics, Inc. today announced financial results for the quarter ending June 30, 2018. The company posted revenue of $1.7 million, up 142% from the prior year quarter, and reported a record number of new agreements signed in […]
Jun 06, 2018 — Accelerate Diagnostics, Inc. announced today it will host symposia on the clinical opportunities of integrating fast, phenotypic susceptibility testing into antimicrobial stewardship programs and its impact on the management of patients with bacteremia at the American Society of Microbiologist Microbe 2018 forum in Atlanta, Georgia.
May 10, 2018 — Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up 51% from the prior year, and reported signed agreements for 345 instruments.
May 03, 2018 — Accelerate Diagnostics, Inc. announced today that performance data will be presented during the Association of Medical Microbiology and Infectious Disease Canada/Canadian Association for Clinical Microbiology and Infectious Disease 2018 congress in Vancouver, Canada, May 2-5 at the Sheraton Vancouver Wall Centre. See the company’s press release for additional details.
Apr 23, 2018 — Hospital Universitario De La Princesa in Madrid, Spain adopts The Accelerate Pheno™ system to shorten adaptation treatment for severe sepsis by 28 hours as compared to the hospital’s conventional system. See the company’s press release for additional details.
Apr 21, 2018 — Accelerate Diagnostics, Inc. today announced the sizeable release of new data presented by the company, its customers, and clinical experts during the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2018, located in IFEMA – Feria de Madrid, Madrid, Spain, April 21 – 24th. Four integrated symposium sessions, 11 poster presentations, and case studies […]
Apr 13, 2018 — Hampshire Hospitals NHS Foundation Trust is first in UK to adopt The Accelerate Pheno™ system to help diagnosis and treat sepsis more rapidly ...
Feb 15, 2018 — Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017. The company reported revenue for Q4 of $2.1 million, doubling revenue for the year, and signed agreements for 337 instruments. Contracts for customer evaluations covered 259 instruments while revenue placements totaled 78 across the U.S., European, and Middle East regions. Net […]